Literature DB >> 19023741

Premorbid intellect and current RBANS performance: discrepancy scores in three geriatric samples.

Kevin Duff1, Mike R Schoenberg, Leigh J Beglinger, David J Moser, John D Bayless, Kennith R Culp, Ryan Carnahan, James W Mold, James G Scott, Russell L Adams.   

Abstract

Assessing cognitive change during a single visit requires the comparison of estimated premorbid abilities and current neuropsychological functioning. As newer instruments are developed to measure current cognitive functioning, their relationships with premorbid estimates need to be evaluated. The current study examined the clinical utility of discrepancy scores between an estimate of premorbid intellect derived from demographic variables (i.e., Barona) and the Total score on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in three geriatric samples. A large community-dwelling "control" sample and two clinical samples were examined. As expected, there was little difference between estimated premorbid intellect and current RBANS Total Scale scores in the community-dwelling sample, while estimated premorbid intellect obtained from the two clinical samples significantly differed from obtained RBANS Total scores. Similar findings were observed on Discrepancy scores for the five Indexes of RBANS. The current findings, along with normative data on these discrepancy scores, can provide additional confidence for clinicians and researchers who need to determine cognitive decline when using these screening measures of neuropsychological status.

Entities:  

Mesh:

Year:  2008        PMID: 19023741     DOI: 10.1080/09084280802325041

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  1 in total

1.  Limitations of a Short Demographic Questionnaire for Bedside Estimation of Patients' Global Cognitive Functioning in Epilepsy Patients.

Authors:  Iris Gorny; Kristina Krause; Anita Albert; Sabrina Schneider; Leona Möller; Lena Habermehl; Adam Strzelczyk; Felix Rosenow; Anke Hermsen; Susanne Knake; Katja Menzler
Journal:  Front Neurol       Date:  2018-03-01       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.